Cargando…
Recent progress and considerations for AAV gene therapies targeting the central nervous system
BACKGROUND: Neurodevelopmental disorders, as a class of diseases, have been particularly difficult to treat even when the underlying cause(s), such as genetic alterations, are understood. What treatments do exist are generally not curative and instead seek to improve quality of life for affected ind...
Autores principales: | Lykken, Erik Allen, Shyng, Charles, Edwards, Reginald James, Rozenberg, Alejandra, Gray, Steven James |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5960126/ https://www.ncbi.nlm.nih.gov/pubmed/29776328 http://dx.doi.org/10.1186/s11689-018-9234-0 |
Ejemplares similares
-
AAV Engineering for Improving Tropism to the Central Nervous System
por: Ghauri, Muhammad S., et al.
Publicado: (2023) -
Engineered AAV vectors for improved central nervous system gene delivery
por: A Kotterman, Melissa, et al.
Publicado: (2015) -
Evaluation of AAV-mediated Gene Therapy for Central Nervous System Disease in Canine Mucopolysaccharidosis VII
por: Gurda, Brittney L, et al.
Publicado: (2016) -
Widespread gene transfer in the central nervous system of cynomolgus macaques following delivery of AAV9 into the cisterna magna
por: Hinderer, Christian, et al.
Publicado: (2014) -
Engineered AAVs for efficient noninvasive gene delivery to the central and peripheral nervous systems
por: Chan, Ken Y, et al.
Publicado: (2017)